Skip to main content
. 2020 Mar 19;10(3):e035114. doi: 10.1136/bmjopen-2019-035114

Table 3.

Assumptions for sample size calculations in two different scenarios

Item CONSORT item Scenario 1. adequate reporting as published in WebCONSORT30 Scenario 2. adapted from scenario 1
1 Outcomes (6a) 77% (79 of 103) 77% (79 of 103)
2 Sample size (7a) 83% (85 of 103) 83% (85 of 103)
3 Sequence generation (8a) 76% (78 of 103) 76% (78 of 103)
4 Allocation concealment (9) 55% (57 of 103) 55% (57 of 103)
5 Blinding (11a) 35% (36 of 103) 35% (36 of 103)
6 Outcomes and estimation (17a 44% (45 of 103) 44% (45 of 103)
7 Harms (19) 71% (73 of 103) 71% (73 of 103)
8 Registration (23) 69% (71 of 103) 90%
9 Protocol (24) 19% (20 of 103) 90%
10 Funding (25) 34% (35 of 103) 90%
Overall 56% 71%

CONSORT, CONsolidated Standards for Reporting Trials